...
【24h】

LC and TLC determination of cinnarizine in pharmaceutical preparations and serum.

机译:LC和TLC测定药物制剂和血清中的肉桂那嗪

获取原文
获取原文并翻译 | 示例
           

摘要

New high performance liquid chromatography (HPLC) and thin layer densitometry (TLC) methods are developed for quantification of cinnarizine in dosage forms in the presence of its photo-degradation products and related substances and in the presence of its metabolites in serum. Mobile phases consisting of benzene-methanol-formic acid (80:17:3) and methanol-acetate buffer of pH 4 (70:30) are satisfactorily used for resolution of cinnarizine from associated substances by TLC and HPLC techniques, respectively. The lower detection limits are 16 and 10 ng microl(-1) of cinnarizine with standard deviations of 1.3 and 1.1% with TLC and HPLC, respectively. The methods are used for assessment of drug purity, stability, bioavailability, bioequivalency and tablet dissolution rate. Four cinnarizine related substances and six drug degradation products are isolated and identified by infrared and mass spectrometry. The results obtained by both techniques are in good agreement and offer the advantages of reproducibility and accuracy.
机译:开发了新的高效液相色谱(HPLC)和薄层光密度测定(TLC)方法,用于在存在光降解产物和相关物质以及存在于血清中的代谢产物的情况下,定量剂型中的肉桂那嗪。分别由TLC和HPLC技术令人满意地使用由苯-甲醇-甲酸(80:17:3)和pH 4的甲醇-乙酸盐缓冲液(70:30)组成的流动相从相关物质中分离肉桂酸。较低的检出限为16和10 ng microl(-1)的肉桂利嗪,TLC和HPLC的标准偏差分别为1.3%和1.1%。该方法用于评估药物纯度,稳定性,生物利用度,生物等效性和片剂溶出率。分离并通过红外和质谱鉴定了四种肉桂利辛相关物质和六种药物降解产物。两种技术获得的结果吻合良好,并具有重现性和准确性的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号